An Alternative Cell Therapy for Cancers: Induced Pluripotent Stem Cell (iPSC)-Derived Natural Killer Cells

Biomedicines

Chao-Lin Liu¹  Li-Jie Hsu²  Chia-Rui Shen²  Ming-Ling Kuo³  Chia-Ning Shen⁴ 

[1] Department of Chemical Engineering, Ming Chi University of Technology, New Taipei 243, Taiwan;Department of Medical Biotechnology and Laboratory Science, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan;Department of Microbiology and Immunology, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan;Genomics Research Center, Academia Sinica, Taipei 115, Taiwan;

关键词: induced pluripotent stem cells (iPSCs);    natural killer cells (NK cells);    cell therapy;   

DOI  :  10.3390/biomedicines9101323

来源: DOAJ

【 摘 要 】

Cell therapy is usually defined as the treatment or prevention of human disease by supplementation with cells that have been selected, manipulated, and pharmacologically treated or altered outside the body (ex vivo). Induced pluripotent stem cells (iPSCs), with their unique characteristics of indefinite expansion in cultures and genetic modifications, represent an ideal cell source for differentiation into specialized cell types. Cell therapy has recently become one of the most promising therapeutic approaches for cancers, and different immune cell types are selected as therapeutic platforms. Natural killer (NK) cells are shown to be effective tumor cell killers and do not cause graft-vs-host disease (GVHD), making them excellent candidates for, and facilitating the development of, “off-the-shelf” cell therapies. In this review, we summarize the progress in the past decade in the advent of iPSC technology and review recent developments in gene-modified iPSC-NK cells as readily available “off-the-shelf” cellular therapies.

【 授权许可】

Unknown